# Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

> **NCT07313579** · — · RECRUITING · sponsor: **Ukrainian Society of Clinical Oncology** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer (GC)
- HIPEC
- Peritoneal Metastases From Gastric Cancer
- Hyperthermic Intraperitoneal Chemoperfusion

## Interventions

- **PROCEDURE:** curative-intent surgery + HIPEC

## Key facts

- **NCT ID:** NCT07313579
- **Lead sponsor:** Ukrainian Society of Clinical Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2030-12-01
- **Final completion:** 2035-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313579, "Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07313579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*